Prev Close | 0.00 |
Day Low/High | 0.00 / 0.00 |
52 Wk Low/High | 0.00 / 0.00 |
Prev Close | 0.00 |
Day Low/High | 0.00 / 0.00 |
52 Wk Low/High | 0.00 / 0.00 |
Exchange | NASDAQ |
Div & Yield | N.A. (N.A) |
Given my risk-averse profile, I made the unusual move last week of buying a basket of biotech stocks. And yesterday, I noted that Biotech Could Be Close to a 'Double Bottom': "I recently created a basket of a dozen speculative and conservative biote...
The iShares Nasdaq Biotechnology ETF (IBB) has tumbled from nearly $400 a share early last summer to around $240 at last check, so I'm taking advantage of today's market schmeissing to purchase a small position in a biotech (biowreck?). I'm buying a...
U.S. stock finished in the red across the board after early gains.
Here's how to lock in gains on risky small-cap biotechnology stocks.
When to take profits is a tricky but important decision.
Fibrocell Science and Prothena have several 'shots on goal.'
IPO Desktop President Francis Gaskins and TheStreet's Debra Borchardt look at the Enanta Pharmaceuticals and Tetraphase Pharmaceuticals offerings.